5-Prenyltryptophol, a new inhibitor of bone morphogenetic protein-induced alkaline phosphatase expression in myoblasts, produced by Streptomyces colinus subsp. albescens HEK608.
Graduate School of Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo, Japan.
Ryuji
R
Uchida
Graduate School of Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo, Japan.
Megumi
M
Nakai
Research Center for Genomic Medicine, Saitama Medical University, Hidaka-shi, Saitama, Japan.
Satoshi
S
Ohte
Faculty of Engineering, Department of Biotechnology, Toyama Prefectural University, Imizu-shi, Toyama, Japan.
Hiroyasu
H
Onaka
Research Center for Genomic Medicine, Saitama Medical University, Hidaka-shi, Saitama, Japan.
Takenobu
T
Katagiri
Graduate School of Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo, Japan.
Hiroshi
H
Tomoda
D030201:Activin Receptors, Type I / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000494:pharmacology*; D002460:Cell Line; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D007211:Indoles / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D051379:Mice; D015394:Molecular Structure; D032446:Myoblasts / Q000187:drug effects* / Q000378:metabolism; D013302:Streptomyces / Q000145:classification / Q000235:genetics / Q000378:metabolism*
C000594036:5-prenyltryptophol; D019485:Bone Morphogenetic Proteins; D007211:Indoles; C425423:ACVR1 protein, human; D030201:Activin Receptors, Type I